- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/542 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/542
Total number of patents in this class: 439
10-year publication summary
|
44
|
40
|
30
|
24
|
32
|
42
|
23
|
32
|
26
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eli Lilly and Company | 4050 |
15 |
| Eisai R&D Management Co., Ltd. | 1172 |
15 |
| Shionogi & Co., Ltd. | 866 |
11 |
| Sentiss Pharma Private Limited | 26 |
10 |
| Erasca, Inc. | 98 |
9 |
| Pfizer Inc. | 3375 |
8 |
| Newave Pharmaceutical Inc. | 71 |
8 |
| Takeda Pharmaceutical Company Limited | 2718 |
7 |
| CalciMedica, Inc. | 92 |
7 |
| F. Hoffmann-La Roche AG | 7847 |
6 |
| Genentech, Inc. | 4090 |
6 |
| Janssen Pharmaceutica N.V. | 3213 |
6 |
| Novartis AG | 10338 |
5 |
| Hoffmann-La Roche Inc. | 3726 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 774 |
5 |
| Wockhardt Limited | 195 |
5 |
| TYK Medicines Inc. | 70 |
5 |
| Rutgers, The State University of New Jersey | 1959 |
4 |
| Santen Pharmaceutical Co., Ltd. | 593 |
4 |
| Shanghai Simr Biotechnology Co., Ltd | 27 |
4 |
| Other owners | 294 |